1. Nonclinical safety assessment of a human interleukin‐22FC IG fusion protein demonstrates in vitro to in vivo and cross‐species translatability. Issue 6 (15th November 2018) Authors: Lee, Donna W.; Zhong, Shelly; Pai, Rama; Rae, Julie; Sukumaran, Siddharth; Stefanich, Eric G.; Lutman, Jeff; Doudement, Estelle; Wang, Xiaoting; Harder, Brandon; Lekkerkerker, Annemarie; Herman, Ann; Ouyang, Wenjun; Danilenko, Dimitry M. Journal: Pharmacology research & perspectives Issue: Volume 6:Issue 6(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized Phase I Healthy Volunteer Study of UTTR1147A (IL‐22Fc): A Potential Therapy for Epithelial Injury. Issue 1 (12th August 2018) Authors: Rothenberg, Michael E.; Wang, Yehong; Lekkerkerker, Annemarie; Danilenko, Dimitry M.; Maciuca, Romeo; Erickson, Rich; Herman, Ann; Stefanich, Eric; Lu, Timothy T. Journal: Clinical pharmacology & therapeutics Issue: Volume 105:Issue 1(2019) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗